H2O2 produced by viridans group streptococci may contribute to inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns

被引:55
作者
Uehara, Y
Kikuchi, K
Nakamura, T
Nakama, H
Agematsu, K
Kawakami, Y
Maruchi, N
Totsuka, K
机构
[1] Nagano Childrens Hosp, Div Clin Pathol, Nagano 3998288, Japan
[2] Nagano Childrens Hosp, Neonatal Intens Care Unit, Nagano 3998288, Japan
[3] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan
[4] Shinshu Univ, Sch Med, Dept Publ Hlth, Matsumoto, Nagano 390, Japan
[5] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan
[6] Shinshu Univ, Sch Allied Med Sci, Dept Med Technol, Div Clin Microbiol, Matsumoto, Nagano 390, Japan
关键词
D O I
10.1086/320179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In an accompanying report, we showed that viridans group streptococci may prevent methicillin-resistant Staphylococcus aureus (MRSA) colonization of the oral cavities of newborns. In the present study, we investigated the mechanism of prevention in vitro. Most viridans group streptococci had bacteriocin-like activity and killed MRSA, Burkholderia cepacia, Enterobacter aerogenes, and Pseudomonas aeruginosa; however, Escherichia coli, Enterobacter cloacae, and Candida albicans were resistant. The activity was induced only by H2O2-secreting strains and was inhibited by horseradish peroxidase or catalase in a dose-dependent manner. The mean concentration of H2O2 produced by 18 strains of viridans group streptococci (1 x 10(8) cfu in 200 muL of culture medium +/- standard deviation was 1.24 +/- 0.60 mmol. Viridans group streptococci inhibited MRSA growth in saliva as well as in culture media. These results indicate that H2O2 produced by viridans group streptococci may inhibit MRSA colonization of oral cavities in newborns.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 21 条
[1]  
Barnard JP, 1999, INFECT IMMUN, V67, P6558
[2]   The alpha-hemolysin of Streptococcus gordonii is hydrogen peroxide [J].
Barnard, JP ;
Stinson, MW .
INFECTION AND IMMUNITY, 1996, 64 (09) :3853-3857
[3]   MUPIROCIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
COOKSON, BD ;
LACEY, RW ;
NOBLE, WC ;
REEVES, DS ;
WISE, R ;
REDHEAD, RJ .
LANCET, 1990, 335 (8697) :1095-1096
[4]   EVALUATION OF THE CAPACITY OF ORAL STREPTOCOCCI TO PRODUCE HYDROGEN-PEROXIDE [J].
GARCIAMENDOZA, A ;
LIEBANA, J ;
CASTILLO, AM ;
DELAHIGUERA, A ;
PIEDROLA, G .
JOURNAL OF MEDICAL MICROBIOLOGY, 1993, 39 (06) :434-439
[5]  
GINBURG I, 1993, FREE RADIC BIOL MED, V14, P495
[6]  
HABY WR, 1995, J INFECT DIS, V171, P614
[7]  
Hillier SL, 1993, CLIN INFECT DIS, V16, P273
[8]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[9]   PRODUCTION OF BACTERICIDAL CONCENTRATIONS OF HYDROGEN-PEROXIDE BY STREPTOCOCCUS-SANGUIS [J].
HOLMBERG, K ;
HALLANDER, HO .
ARCHIVES OF ORAL BIOLOGY, 1973, 18 (03) :423-+
[10]   COMPARISON OF PHENOTYPIC CHARACTERISTICS, DNA-DNA HYBRIDIZATION RESULTS, AND RESULTS WITH A COMMERCIAL RAPID BIOCHEMICAL AND ENZYMATIC-REACTION SYSTEM FOR IDENTIFICATION OF VIRIDANS GROUP STREPTOCOCCI [J].
KIKUCHI, K ;
ENARI, T ;
TOTSUKA, KI ;
SHIMIZU, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1215-1222